The impact of heart failure severity at time of listing for cardiac transplantation on survival in pediatric cardiomyopathy

Journal of Heart and Lung Transplantation

Volumn 30, Issue 7, 2011, Pages 755-760

  Larsen, Ranae L ^a   Canter, Charles E ^b   Naftel, David C ^c   Tressler, Margaret ^c   Rosenthal, David N ^d   Blume, Elizabeth D ^e   Mahle, William T ^f   Yung, Delphine ^g   Morrow, William R ^h   Orav, E John ^e   Wilkinson, James D ⁱ   Towbin, Jeffrey A ^j   Lipshultz, Stephen E ⁱ  

^a LOMA LINDA UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Alabama at Birmingham   (United States)

^d STANFORD UNIVERSITY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

ⁱ UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF CINCINNATI   (United States)

more..

Author keywords

cardiomyopathy; heart failure; heart transplantation; mortality; pediatrics

Indexed keywords

INOTROPIC AGENT;

ARTICLE; ARTIFICIAL VENTILATION; CARDIAC PATIENT; CARDIOMYOPATHY; CHILD; CIRCULATION; DISEASE SEVERITY; FEMALE; GRAFT SURVIVAL; HEART FAILURE; HEART LEFT VENTRICLE MASS; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; PRIORITY JOURNAL; SCORING SYSTEM;

ASSISTED CIRCULATION; CARDIOMYOPATHIES; CARDIOTONIC AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; MALE; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RISK; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME; WAITING LISTS;

EID: 79959199976     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2011.01.718     Document Type: Article

References (30)

1. C.E. Canter, R.E. Shaddy, and D. Bernstein Indications for heart transplantation in pediatric and congenital heart disease An American Heart Association Scientific Statement Circulation 115 2007 658 676
2. S.E. Lipshultz, L.A. Sleeper, and J.A. Towbin The incidence of pediatric cardiomopathy in two regions of the United States N Eng J Med 348 2003 1647 1655 (Pubitemid 36459470)
3. C.E. Canter, and P.F. Kantor Heart transplant for pediatric cardiomyopathy Prog Pediatr Cardiol 23 2007 67 72 (Pubitemid 47176921)
4. A.E. Tsirka, K. Trinkaus, and S.-C. Chen Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation J Am Coll Cardiol 44 2004 391 397 (Pubitemid 38950600)
5. P.F. Kantor, J.R. Abraham, A.I. Dipchand, L.N. Benson, and A.N. Redington The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy J Am Coll Cardiol 55 2010 1377 1384
6. L.M. Russo, and S.A. Webber Idiopathic restrictive cardiomyopathy in children Heart 91 2005 1199 1202 (Pubitemid 41192399)
7. R. Kirk, L.B. Edwards, and P. Aurora Registry of the International Society for Heart and Lung Transplantation: eleventh official pediatric heart transplantation report2009 J Heart Lung Transplant 28 2009 993 1006
8. A.I. Dipchand, D.C. Naftel, and B. Feingold Outcomes of children with cardiomyopathy listed for transplant: a multi-institutional study J Heart Lung Transplant 28 2009 1312 1321
9. K. Lietz, and L.W. Miller Improved survival of patients with end-stage heart failure listed for heart transplantation J Am Coll Cardiol 50 2007 1282 1290
10. J. Jimenez, L.B. Edwards, R. Higgins, J. Bauerlein, S. Pham, and S. Mallon Should stable UNOS status 2 patients be transplanted? J Heart Lung Transplant 24 2005 178 183 (Pubitemid 40215594)
11. H. Krakauer, M. Jia-Yeong, and R.C. Bailey Projected survival benefit as criterions for listing and organ allocation in heart transplantation J Heart Lung Transplant 24 2005 680 689 (Pubitemid 40798250)
12. J.K. Kirklin, D.C. Naftel, and R.L. Caldwell Should Status II patients be removed from the pediatric heart transplant waiting list? A multi-institutional study J Heart Lung Transplant 25 2006 271 275 (Pubitemid 43290655)
13. M.A. Grenier, S.K. Osganian, and G.F. Cox Design and implementation of the North American Pediatric Cardiomyopathy Registry Am Heart J 139 2000 S86 S95
14. D.T. Hsu, D.C. Naftel, and S.A. Webber Lessons learned from the Pediatric Heart Transplant Study Congenital Heart Disease 1 2006 54 62 (Pubitemid 43805646)
15. Van Meter CH, Heiney DA. Modifications to and implementation of UNOS policy 3.7 (Allocations of thoracic organs). UNOS policy communication. United Network for Organ Sharing, PO Box 13770, Richmond VA, December, 1998.
16. D.C. McGiffin, D.C. Naftel, and J.K. Kirklin Predicting outcome after listing for heart transplantation in children: comparison of Kaplan-Meier and parametric competing risk analysis J Heart Lung Transplant 16 1997 713 722 (Pubitemid 27319147)
17. L.W. Stevenson, S.L. Warner, and M.A. Hamilton Modeling distribution of donor hearts to maximize early candidate survival Circulation 86 suppl II 1992 II-224 II-230
18. N.A. Mokadam, G.A. Ewald, R.J. Damiano, and N. Moazami Deterioration and mortality among patients with United Network for Organ Sharing status 2 heart disease: Caution must be exercised in diverting organs J Thorac Cardiovasc Surg 131 2006 925 926
19. UNOS Board of Directors Policy 3.7 Organ Distribution: Allocation of thoracic organs http://www.unos.org/PoliciesandBylaws2/policies/pdfs/policy-9. pdf Accessed April 15, 2010
20. J.N. Nativi, A.G. Kroury, and C. Myrick Effects of the 2006 U.S. thoracic organ allocation change: Analysis of local impact on organ procurement and heart transplantation J Heart Lung Transplant 29 2010 235 239
21. J.D. Vega The change in heart allocation policy in the United States: is it working as designed? J Heart Lung Transplant 29 2010 255 256
22. M.R. Johnson, K.H. Meyer, J. Haft, D. Kinder, S.A. Webber, and D.B. Dyke Heart transplantation in the United States, 19992008 Am J Transplant 10 2010 1035 1046
23. A.I. Dipchand, D.C. Naftel, and B. Feingold Outcomes of children with cardiomyopathy listed for transplant: a multi-institutional study J Heart Lung Transplant 28 2009 1312 1321
24. C.S.D. Almond, R.R. Thiagarajan, and G.E. Piercey Waiting list mortality among children listed for heart transplantation in the United States Circulation 119 2009 717 727
25. B. Zethelius, L. Berglund, and J. Sundstrm Use of multiple biomarkers to improve the prediction of death from cardiovascular causes N Engl J Med 358 2008 2107 2116 (Pubitemid 351679597)
26. E. Braunwald Biomarkers in heart failure N Engl J Med 358 2008 2148 2159
27. R.E. Shaddy, M.M. Boucek, D.T. Hsu Pediatric Carvedilol Study Group Carvedilol of children and adolescents with heart failure: a randomized controlled trial JAMA 298 2007 1171 1179 (Pubitemid 47403103)
28. E. Azeka, J.A. Franchini Ramires, and C. Valler Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment J Am Coll Cardiol 40 2002 2034 2038 (Pubitemid 35425373)
29. S.M. Rivenes, D.L. Kearney, E.O. Smith, J.A. Towbin, and S.W. Denfield Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy Circulation 102 2000 876 882
30. A.P. Goldman, J. Cassidy, and M. de Leval The waiting game: bridging to paediatric heart transplantation Lancet 362 2003 1967 1970 (Pubitemid 37548420)